Arrowhead Pharmaceuticals Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep 2025Sep 2024Sep 2023Sep 2022Sep 2021
Valuation Ratios
P/S Ratio5.75678.1211.9614.3847.07
P/B Ratio9.4712.6010.038.3615.92
Price/Tangible Book10.3813.6111.039.0516.47
Price/FCF30.3944.05
Price/OCF26.5637.99
Enterprise Value Ratios
EV/Revenue5.53686.0211.6313.0943.51
EV/EBITDA37.52
EV/EBIT46.65
EV/FCF29.2540.72
Profitability & Returns
Return on Equity (ROE)0.09%-2.55%-0.59%-0.43%-0.32%
Return on Assets (ROA)0.05%-0.39%-0.18%-0.16%-0.15%
Return on Invested Capital (ROIC)0.17%-1.88%-1.01%-1.81%-1.27%
Return on Capital Employed (ROCE)0.08%-0.58%-0.31%-0.32%-0.26%
Leverage & Solvency Ratios
Debt/Equity1.484.461.330.200.06
Debt/EBITDA5.36
Debt/FCF4.740.17
Liquidity Ratios
Current Ratio4.866.743.952.922.63
Quick Ratio4.736.573.752.672.58
Efficiency Ratios
Asset Turnover0.660.000.330.350.22
Yield & Distribution Ratios
Earnings Yield0.00%-0.25%-0.07%-0.05%-0.02%
FCF Yield0.03%-0.25%-0.11%-0.05%0.02%
Buyback Yield-0.12%-0.12%-0.01%-0.02%-0.03%